enGene Holdings Inc.
For the period ended Oct 31, 2025. Filed Dec 22, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Dec 22, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| enGene Holdings Inc. | ||
| Date: December 22, 2025 | By: | /s/ Ronald H. W. Cooper |
|---|---|---|
| Name: Ronald H. W. Cooper | ||
| Title: Chief Executive Officer and President | ||
Pursuant to the requirements of the Securities Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Ronald H. W. Cooper | Chief Executive Officer, President and Director(Principal Executive Officer) | December 22, 2025 |
| Ronald H. W. Cooper | ||
| /s/ Ryan Daws | Chief Financial Officer(Principal Financial Officer and Principal Accounting Officer) | December 22, 2025 |
| Ryan Daws | ||
| /s/ Philip Astley-Sparke | Director | December 22, 2025 |
| Philip Astley-Sparke | ||
| /s/ Michael Heffernan | Director | December 22, 2025 |
| Michael Heffernan | ||
| /s/ Gerald Brunk | Director | December 22, 2025 |
| Gerald Brunk | ||
| /s/ Dr. Richard Glickman | Director | December 22, 2025 |
| Dr. Richard Glickman | ||
| /s/ Dr. William Grossman | Director | December 22, 2025 |
| Dr. William Grossman | ||
| /s/ Paul Hastings | Director | December 22, 2025 |
| Paul Hastings | ||
| /s/ Wouter Joustra | Director | December 22, 2025 |
|---|---|---|
| Wouter Joustra | ||
| /s/ Lota Zoth | Director | December 22, 2025 |
| Lota Zoth | ||
i
INDEX TO FINANCIAL STATEMENTS
| Page | |
| Report of Independent Registered Public Accounting Firm | F-2 |
|---|---|
| Consolidated Balance Sheets as of October 31, 2025 and 2024 | F-3 |
| Consolidated Statements of Operations and Comprehensive Loss for the Years Ended October 31, 2025 and 2024 | F-4 |
| Consolidated Statements of Shareholders’ Equity for the Years Ended October 31, 2025 and 2024 | F-5 |
| Consolidated Statement of Cash Flows for the Years ended October 31, 2025 and 2024 | F-6 |
| Notes to Consolidated Financial Statements | F-7 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.